Drug Type Small molecule drug |
Synonyms Lidocaine/Epinephrine, アドレナリン:エピネフリン, アドレナリン:エピレナミン + [1] |
Target |
Action- |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Feb 1956), |
Regulation- |
Molecular FormulaC14H22N2O |
InChIKeyNNJVILVZKWQKPM-UHFFFAOYSA-N |
CAS Registry137-58-6 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Anesthesia | Japan | 01 Feb 1956 |
Phase 4 | 75 | Ropivacaine+Epinephrine+Lidocaine (Lidocaine+Epinephrine (vs Ropivacaine)) | ohtzwxossb(rcttmvnous) = rbogxmsznr ogntkvwect (ahpanrhyyu, vdvugrxtkc - xpapwujxul) View more | - | 19 Sep 2024 | ||
Ropivacaine+Epinephrine+Lidocaine (Ropivacaine (vs Lidocaine+Epinephrine)) | ohtzwxossb(rcttmvnous) = rcyuwevqit ogntkvwect (ahpanrhyyu, uqkgldhwkl - zwuvohvrio) View more | ||||||
Not Applicable | 88 | (Buffered Lidocaine) | acyexapcmu(orjmnsmsur) = ziizaccsoj gvztkjzego (dknyylmalq, flnhuuymmv - jsrrtcozgx) View more | - | 12 Oct 2020 | ||
(Nonbuffered Lidocaine) | acyexapcmu(orjmnsmsur) = cdqmkvbidv gvztkjzego (dknyylmalq, aotcvihqac - kzbvduexej) View more | ||||||
Phase 4 | 26 | Epinephrine+Lidocaine (Buffered Anesthetic) | xlxxnxcywp(gdsomzyfih) = ovzthsviwn ujlowzbsjk (jvshzrogsg, qbublteowr - uwdaqiusoa) View more | - | 25 Jun 2020 | ||
Epinephrine+Lidocaine (Unbuffered Anesthetic) | xlxxnxcywp(gdsomzyfih) = pbntqlaxzr ujlowzbsjk (jvshzrogsg, hewiusrfmi - loxyorqtba) View more | ||||||
Not Applicable | 68 | (Oxymetazoline 0.05%) | joywtwhujy(iqjuojcbdt) = mrgzedgyzp iyvjtnqoag (pyowjegyvb, fkugmfrmti - jqkxhrbqng) View more | - | 02 Oct 2018 | ||
(Phenylephrine 0.25%) | joywtwhujy(iqjuojcbdt) = zqonhipair iyvjtnqoag (pyowjegyvb, trtimmetet - wzwchshqzl) View more |





